Dr Sally Ann Forsyth, CEO of Stevenage Bioscience Catalyst (SBC), thanks her colleagues and collaborators after being honoured in the 2021 New Year Honours list. Sally Ann has been awarded an Officer of the Order of the British Empire (OBE) for services to business and science.
NanoSyrinx announces the appointment of Dr Jane Dancer to its Board as Non-Executive Director. Dr Dancer has over 30 years’ experience in business development across biotech, pharma and agrochemicals and her experience will help to drive NanoSyrinx’s ongoing fundraising activities and ambitious growth plans.
Global Life Sciences search specialist, Coulter Partners and BioInnovation Institute (BII), the international incubator in Denmark for research-based innovation and entrepreneurship, are delighted to announce a ground-breaking collaboration agreement.
Global executive search specialist, Coulter Partners is delighted to announce a number of key hires in 2020. Marianne McNamara, SHRM-SCP has joined as Operations Director for the US, while Evan Fishel is appointed Director on the West Coast and Mike Miano, Senior Associate in New Jersey. In London the team is strengthened with Ben Hobbins as Senior Consultant and Hafsah Bhatti as Associate, while research capacity is also expanded across the team.
Enesi Pharma is delighted to announce the appointment of Dr Keith Howard as Chief Scientific Officer. Dr Howard is a seasoned vaccine development expert who will lead Enesi’s R&D efforts to develop novel solid-dose vaccines for needle-free delivery for both in-house and partnered programmes, progressing them into clinical development.
The UK Government grant will support new and existing projects until March 2022. Funding will ensure that the positive impact of the ATTC network continues; further optimising the UK ecosystem for routine adoption of advanced therapies.
Precision medicine company PrecisionLife has appointed Simon Beaulah as SVP of Healthcare and Head of US Operations. Simon’s appointment demonstrates the company’s focus on developing the US market and its commercial profile within the healthcare and precision medicine fields. Simon brings with him a wealth of experience, having spent more than 20 years leading product and business strategy and teams for innovative informatics businesses in the healthcare and life science ecosystems.